A B S T R A C T A technique was developed and evaluated using the exponential infusion of positron-emitting diffusible tracers Actual and estimated flow correlated significantly for both the 14 KH-RBC hearts infused with H2'50 (r = 0.90, n = 89 determinations) and the 3 KH-RBC hearts infused with ["Cibutanol (r = 0.93, n = 13 determinations). In addition, the required exponentially increasing arterial tracer concentrations were shown to be attainable in vivo in dogs and rhesus monkeys after intravenous exponential administrations of tracer. The results suggest that the approach developed employing exponential tracer infusion permits accurate measurement of myocardial perfusion and that it should prove useful in the noninvasive measurement of regional myocardial perfusion in vivo by positron emission tomography.
A B S T R A C T A technique was developed and evaluated using the exponential infusion of positron-emitting diffusible tracers to quantitate myocardial perfusion. The approach employs a parameter that rapidly reaches a constant value as a function of tracer delivery rate, isotope decay constant, and the monotonically increasing tissue radioactivity. Isolated rabbit hearts with controlled flow were used to evaluate the approach, because tracer kinetics in such preparations mimic those in vivo. Accordingly, exponential infusions of H2150 and ["1C]butanol were administered to 25 isolated rabbit hearts perfused with Krebs-Henseleit solution (KH) alone or KH enriched with erythrocytes (KH-RBC, hematocrit = 40). With flow varied from 1.2 to 5 ml/g per min in eight KH hearts infused with H2150, actual and estimated flow correlated closely (r = 0.95, n = 52 determinations). For the KH-RBC hearts, flow was varied from 0.3 to 1.5 ml/g per min. Actual and estimated flow correlated significantly for both the 14 KH-RBC hearts infused with H2'50 (r = 0.90, n = 89 determinations) and the 3 KH-RBC hearts infused with ["Cibutanol (r = 0.93, n = 13 determinations). In addition, the required exponentially increasing arterial tracer concentrations were shown to be attainable in vivo in dogs and rhesus monkeys after intravenous exponential administrations of tracer. The results suggest that the approach developed employing exponential tracer infusion permits accurate measurement of myocardial perfusion and that it should prove useful in the noninvasive measurement of regional myocardial perfusion in vivo by positron emission tomography.
INTRODUCTION
Positron emission tomography (PET),' an intrinsically quantitative tool, has been applied rapidly to nonReceived for publication 21 November 1979 and in revised form 7 July 1980. 'Abbreviations used in this paper: KH, Krebs-Henseleit buffer; KH-RBC, Krebs-Henseleit buffer enriched with erythrocytes; PET, positron emission tomography.
918
invasive assessment of myocardial metabolism. Its successful application for quantification of regional perfusion is hampered by several serious difficulties, however. Our study was designed to develop and evaluate a novel mathematical approach to quantifying myocardial perfusion, employing exponential infusion of diffusible tracers. The tracers were selected to embody physical characteristics particularly attractive for ultimate quantitative applications in patients. The approach was designed to permit use of radionuclides with relatively long physical half-lives amenable to quantification by PET. An ideal tracer should exhibit several additional characteristics, including free diffusibility and an extraction fraction uninfluenced by either residence time per se or by alterations of myocardial metabolism induced by ischemia. In the initial experiments in our study with isolated perfused hearts, a less-than-ideal but easily prepared tracer, H2'5O, was used to define the feasibility of the overall concept. Subsequently, studies were performed with ["lC]-butanol, synthesized for this purpose because its lipid: aqueous partition coefficient is near unity and because of its high diffusivity in tissue (1) . The (2) (3) (4) . In the case of the heart, regional myocardial tracer activity reaches 98% of the steady-state value after six half-lives, based on the combined physical decay and biological turnover rate constants. Thus, a steady-state value can be considered to have been reached at time t based on the following An initial approach to obviating some of these limitations entails an exponential infusion to replace constant infusion of isotope so that the infusion rate constant (,3) would be equal to but opposite in sign to the isotope physical decay constant (a). That is, tracer delivery would conform to the function CB(t) = CB'el". With such an infusion, a constant activity source of tracer is not required. Based on mathematical considerations (see Appendix), however, it became apparent that by driving the delivery of tracer so that the exponential constant (p) exceeds the isotope physical decay rate constant (a), the time required for estimation of flow could be decreased, recirculation artifact could be minimized, and the estimate of flow could be made less sensitive to measurement errors. For this case, tracer delivery conforms to the function CB(t) = CB'eI3.
The exponential infusion does not result in steady-state activity in the myocardium. However, it does give rise to a derived activity function (q*), which includes as one parameter the actual activity of tracer in myocardium (q) and which reaches a plateau value ("steady state") (Fig. 1) (Table I) .
Recirculation artifact is reduced by use of the exponential infusion approach. Because tracer is infused at a progressively increasing rate, the concentration of tracer recirculated from that delivered previously is small compared to tracer administered from the infusion pump. For example, in the case of constant infusion of H2150 (t412 = 123 s) under conditions in which the mean transit time of the tracer through the circulatory system is 1 min, a conservative estimate of average activity of the recirculating tracer would be 71% of the initial activity. However, in the case of an exponential infusion with an infusion half-time of 30 s, the average activity of tracer due to recirculation after a single pass would be 18%. METHODS Exponential infusion in vivo. Applications in vivo of the approach developed would obviously require a systemic arterial blood tracer time-activity curve that exhibits an exponentially increasing concentration when a peripheral, intravenous infusion of tracer is used. In view of the potential difficulties from mixing in vivo, it was necessary to determine whether this condition could be met easily in large experimental animals. Experiments were therefore performed with rhesus monkeys and dogs anesthetized with phencyclidine and pentobarbital, respectively. Exponential intravenous infusions of H2'50 and of '"C-tracers were implemented via the femoral vein with a stepping motor-driven infusion pump. The speed of the motor and hence the delivery rate were microcomputer controlled such that the desired delivery rate constant for each infusion could be selected by the operator. Determninations ofthe arterial concentration oftracer as a function of time during the femoral vein infusions in six monkeys were based on activity measured in a well counter from serial samples (10-s intervals) ofblood from a cannulated carotid artery. Similar experiments were performed in two dogs with carotid arterial blood withdrawn with a constant withdrawal pump at 20 ml/min. Continuous time-activity curves were obtained from the cannula activity in the coincidence mode by the NaI(T1) system described below. Arterial blood concentrations were corrected for isotope physical decay. Selected exponential infusion pump rate constants ((3)ranged from 0.069 to 0.017 s-', corresponding to infusion half-times of 10 to 40 s, respectively.
Isolated perfused hearts. The exponential infusion approach for delivery of tracer and estimation of coronary flow by external detection of a position-emitting radionuclide was evaluated with the use of isolated perfused rabbit hearts.
We have previously shown that this preparation is particularly useful in characterizing behavior oftracers with potential applicability for imaging in vivo, because it permits assessment of tracer kinetics under conditions in which flow and metabolic behavior of the heart can be controlled and monitored independently and precisely. In addition, such preparations permit evaluation of behavior of the tracer under conditions in which concentrations in the perfusate of substrate, protein, hormones, and other moieties potentially present in vivo can be controlled, and in which recirculation can be excluded, included, or simulated to permit assessment of its possible effects on accumulation of tracer in vivo. By inclusion of washed sheep erythrocytes in the perfusion medium to enhance oxygen-carrying ability, perfusion can be performed under conditions in which the absolute magnitude of flow simulates flow in vivo, a particularly important consideration in this study since the kinetics of a tracer with bufferperfused hearts may be influenced by the shorter residence time associated with the high flow rates conventionally required to provide adequate oxygenation of buffer-perfused hearts.
Hearts were isolated from New Zealand white rabbits weighing 2-3 kg and perfused retrograde through the aorta as described previously in detail (5) . Briefly, hearts were perfused with or without washed sheep erythrocytes at a hematocrit of 40, suspended in modified Krebs-Henseleit solution containing 0.4 mM (27.6 g/liter) bovine serum albumin (at levels approximating those in plasma). The endogenous albumin-bound fatty acid content was 0.1±0.01 mM, (SD), based on direct assays of the albumin solutions. Albumin was obtained as Cohn fraction V from the Sigma Chemical Co., St. Louis, Mo. The Krebs-Henseleit buffer (with 5 mM glucose and 70 mU/ml insulin) contained the following ions in milliequivalents per liter: Na+, 143; Cl-, 128; K+, 6.1; Ca++, 2.5; Mg++, 1.2; SO=, 1.2; H2PO0, 1.4. All buffer solutions were dialyzed extensively before use and filtered through a 0.45 ,&m filter. Sheep erythrocytes were used because of their small size and because their affinity forf oxygen is less dependent on the concentration of 2,3-diphosphoglycerate in contrast to cells from many other species. All hearts were flushed initially with modified Krebs-Henseleit solution (KH) to wash out platelets and other blood elements that might lead to microaggregation and impair perfusion later. Within 2 min after excision of the heart, the pulmonary artery was cannulated and the caval and pulmonary vessels ligated. 90-95% of total flow and virtually all nutritional flow (excluding flow through the Thebesian system) was collected via the pulmonary artery. Isovolumically beating hearts were prepared by passing a fluid-filled latex balloon into the left ventricle via the left atrium. With the balloon connected to a Gould P23Db pressure transducer (Gould, Inc., Instruments Division, Cleveland, Ohio), left ventricular pressure and dPldt (obtained by electronic differentiation) were recorded continuously. Perfusion pressure was monitored with the use of a side-arm cannula immediately distal to the aortic valve. Coronary flow was monitored by timed collections of effluent from the pulmonary artery. Drainage from Thebesian flow and any retrograde ventricular filling resulting from occult aortic insufficiency were monitored via a left ventricular stab wound; both were found to comprise <10% of pulmonary outflow in all hearts. Left ventricular end-diastolic pressure was adjusted by changing the volume of the balloon and was maintained at 10 mm Hg. The isolated heart was enclosed in a water jacket to maintain myocardial temperature at 37°C (verified by monitoring with a thermistor in some experiments) and paced at a rate of 180 beats/min with the use of pacing electrodes sutured onto the left ventricle.
Perfusion was initiated with either KH alone or with KH enhanced with erythrocytes (KH-RBC). The perfusion rate in hearts perfused with buffer alone was adjusted to 4.2 ml/g wet wt per min with a constant flow roller pump (a value obtained in a previous study with hearts perfused with erythrocyte-free buffer at a constant pressure of 60 mm Hg and found to provide adequate oxygenation based on stability of the preparation and ventricular performance). In hearts perfused with KH-RBC, the initial flow rate was 1.4 ml/g per min, since under these conditions, ventricular, mechanical, and metabolic performance were stable, reflecting adequate oxygenation. When hearts were perfused with buffer alone (without erythrocytes), the perfusate was equilibrated with 95% oxygen and 5% CO2 through a Silastic membrane as previously described (5) . When erythrocytes were used in the buffer, equilibration was accomplished with room air and sufficient CO2 to maintain pCO2 in the perfusate (monitored with an IL-213 blood gas meter [Instrumentation Laboratory, Inc., Watertown, Mass.]) within the physiological range. The salutary effects of erythrocyte-enhanced buffer perfusion on physiological and metabolic parameters in this preparation have been documented previously (5) .
Preparation of radioactive tracers. H2'50 was prepared with the Washington University Allis Chalmers Cyclotron as previously described (6) . ["C]butanol was prepared from "CO2 by the N-propyl magnesium chloride reaction (1) .
Detection of tracer activity. Cardiac radioactivity time-activity curves were obtained generally as previously described (7). 50-100 ,uCi of H2'50 (physical t12 = 123 s) or ["C]-butanol (physical t112 = 20.4 min) was infused at an exponentially increasing rate with a half-time of 30 s into the perfusate 1 cm distal to the aortic valve, through a side arm in the aortic cannula to assure adequate mixing. The infusion pump was controlled by a MITs microcomputer (Pertec Computer Corp., Chatsworth, Calif.) used also for data collection and analysis. Time-activity curves were recorded with two NaI(TI) detectors placed 1800 apart, -3 cm from the surface of the heart at the midventricular level. Simultaneous detection with each of the two detectors ofactivity within their colinear fields of view permits coincidence detection of pairs of511 keV photons emitted as a result of positron annihilation, with measured background activity of virtually zero. The detectors were aligned so that the percentage of coincidence counts represented --10% of singles, verified before each experiment with the use of a standard germanium-68 source inserted in the field of view. Events were recorded with Ortec model 485 amplifiers, model 488 single channel analyzers, and a model 414A fast coincidence unit (Ortec Inc., EG&G, Inc., Oak Ridge, Tenn.) as previously described (7) . Output was monitored on-line and collected with a microcomputer system to correct residue detection curves for physical decay of the tracer and to provide the mathematical analysis used to obtain estimates of flow.
Exponential infusion in isolated perfused hearts. 25 isolated hearts were randomized after initial equilibration, and perfusion was maintained with either KH alone or KH-RBC. Hearts were then equilibrated for an additional 20 min, during which period hearts were discarded that did not generate developed left ventricular systolic pressure >60 mm Hg (a total of six). After the second equilibration, exponential infusion of tracer was initiated under conditions of control flow (4.2 ml/g per min in KH hearts and 1.4 mllg per min in KH-RBC hearts). After a 10-min interval, during which the myocardial time-activity curves were obtained, and at a time when background activity had declined to preinfusion values, the perfusion rate was reduced in a stepwise fashion, first to 50% and then to 25% of control flow; repeat exponential in-fusions of tracers were implemented, and tissue time-activity curves were obtained.
Two tracers were used for this purpose. (Fig. 2) .
RESULTS
Feasibility of obtaining required exponentially increasing concentrations oftracer in arterial blood in vivo. As shown in Table II , the observed blood timeactivity curve in dogs and rhesus monkeys after peripheral intravenous exponential infusions exhibited the desired monoexponential behavior, with rate constants of the observed curves directly related to the rate constants selected for the exponential infusions. Thus, the fit of the arterial blood time-activity data to a monoexponential function was consistently close (r > 0.95; n = 24 experiments). However, the observed rate constant was not equal to the infusion rate constant. This implies that the arterial blood concentration must be monitored. For Refinements ofdata analysis. Although the correlation coefficients indicate a high degree of linearity for all hearts, the estimated tracer blood:tissue partition coefficients (A) varied considerably among hearts from the predicted values of 0.77 for the H2150 group in KHperfused hearts, 0.90 for the H2150 and KH-RBC perfused group, and 1.0 for ["C]butanol-KH-RBC perfused hearts. Accordingly, we considered the likelihood that our measured tissue tracer activity may have been affected by some tracer retained in the cardiac chambers. Such retention is characteristic of the exper- 2.01 the right atrium, for the assessment of right heart tracer turnover rate (KR), or into a cannula passed into the balloon-filled left ventricle via the left atrium, for the assessment of the left ventricular chamber tracer turnover rate (KI) . The values obtained for KR and KL were linear functions ofpulmonary outflow and left ventricular leakage flow, respectively, with an average correlation coefficient of 0.91. Using experimentally determined values for KR and KL, we performed an additional series of experiments in which we corrected the measured tissue tracer activity for activity found in the chambers, as outlined in Appendix 2. Six hearts perfused with KH-RBC were studied with H2150, and three hearts perfused with KH-RBC were studied with ["C]-butanol. The recorded time-activity data was transformed to reflect only the myocardial tracer activity, as outlined in Appendix 2, and utilized to obtain plots of ,13/F, vs. CB'/q*. The correlation coefficients and estimated partition coefficients obtained in this fashion are shown in Table III . As shown in Fig. 4 , plots made for all hearts studied with H2150 and with ["C]butanol exhibited composite correlation coefficients of 0.99 (n = 41 determinations) and 0.92 (n = 6 determinations), respectively. Furthermore, the estimated partition coefficients did not differ significantly, at the P = 0.005 level, from the known partition coefficient (A) of each tracer. These results indicate that the scatter in the estimates of A evident in the earlier results with isolated hearts was attributable to contributions from tracer retained in the cardiac chambers in such preparations. Furthermore, by incorporating the slopes of the External Quantification of Perfusion NORMALIZED -CJ ci FIGURE 4 Results with exponential infusions with H2150 in six KH-RBC perfused hearts with data corrected for chamber activity. Axes and symbols are defined as in Fig. 3 . veloped to assess regional myocardial perfusion externally (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) , each entails some unavoidable limitations. One approach that has been employed, namely constant infusion of a diffusible tracer, suffers from potential constraints discussed in the Introduction.
Although the isolated perfused heart preparation is a simple preparation in contrast to the use of intact experimental animals and patients, it permits control of flow and exclusion of recirculation under conditions in which the metabolic environment and physiological demands of the heart can be controlled and monitored. Analysis of behavior of tracer in such preparations permits delineation ofthe relative quantitative importance of specific, potentially influential, biological factors. Accordingly, the approach developed and evaluated in this study for external assessment of regional coronary perfusion was tested initially in isolated perfused hearts and applied to global perfusion only.
Results obtained indicate that the programmed exponential infusion technique provides a promising approach for externally assessing myocardial perfusion with positron radionuclides, with results of estimated flow conforming to actual flow over a wide range despite marked variation of myocardial metabolism induced by low flow.
Clinical implications. Results ofthis study indicate that the exponential infusion technique is potentially applicable to external assessment of regional myocardial blood flow in vivo in experimental animals and ultimately in patients. The results show that the required coronary artery tracer concentration can be achieved in vivo by exponential intravenous adminis-tration of isotope in dogs, and that close correlations are observed between estimated and independently measured flow in isolated rabbit hearts. [11C]Butanol was selected because its lipid:aqueous partition coefficient should avoid potential artifacts from heterogeneous distribution of cardiac lipid constituents in vivo. It has been synthesized successfully (1) . Calculations indicate that the exponential infusion required will entail lower organ radiation burdens than encountered with the constant infusion method (e.g., 93% less for the case of [11C]butanol).
In the current study with isolated hearts, CB' had to be calculated (Appendix 1), and corrections had to be made for tracer in the right and left heart chambers. These methodological considerations apply only for the particular preparation used, the isolated perfused heart. For patient studies, a gated tomographic scan will be performed with either ["1C]palmitate or "1CO-hemoglobin to outline the ventricular myocardium and the heart chambers. The tracer used for measurement of myocardial blood flow will be infused exponentially via a peripheral vein and gated tomographic scans will be obtained. Gating will facilitate definition and differentiation of tracer in the blood from that in the myocardium, and will reduce partial volume effects of the beating heart. Myocardial activity (q[t]) and ventricular chamber blood activity (CB[t]) will be obtained simultaneously from each tomographic slice.
CB' (blood activity at time 0) will be calculated by fitting a monoexponential function to chamber blood activity (CB[t]) obtained from serial scans and extrapolating the exponential to time 0. The derived steadystate function (q*) will be calculated based on myocardial activity (q[t]) (Eq. 3) after the pseudosteadystate level has been achieved (Eq. 4).
Although gating will decrease the number of counts recorded per second, counting statistics for the myocardial tissue activity can be controlled by the total scan time. Because the technique provides a value ofthe derived myocardial tracer activity function (q*) that remains constant once it plateaus, the total scan time can be manipulated to ensure adequate counting statistics. Counting statistics for ventricular cavity blood activity can be optimized by integrating counts from all positions of the chamber common to systole and diastole. Thus, the model parameters CB' and ,B can be determined from the serial gated scans of the ventricular blood activity, and the model parameter q* can be determined regionally from the gated scan of the myocardium, based on consideration of the elapsed time from the onset of the exponential infusion (Eq. 3). The tissue:blood partition coefficient (X) is a previously experimentally determined quantity of the tracer. Regional myocardial mass and, by calculation, flow/mass, can be determined from definition of pixel size and depth. We have shown that the resolution of the PET instrument is sufficient to permit quantification of the regional distribution of tracer within hearts of patients during imaging, and that regional tissue mass can be determined accurately and reproducibly by knowing pixel size and depth (19) (20) (21) 
3 CB' 1 (12) F q* X However, for the isolated heart preparation using a pair of coincident scintillation probes, the parameters CB and q can be measured only indirectly. Because of the geometrical External Quantification of Perfusion 925 (7) dependence of the response of the probes, it is impossible to calibrate directly an independent arterial blood tracer concentration measuring device with the probe system. In addition, the scintillation detectors do not record all of the positron emissions from the isolated heart, but only -10% under the conditions employed. Therefore, we devised a parameter estimation scheme in which a series of exponential infusions are performed on each heart at selected flows. The parameter CB is derived as a ratio from each infusion referenced to the first infusion as follows:
Cpi(t) Ai Fo*K Ai*Fo Cpo(t) Ao-Fi-K Ao-Fi (13) where Cpi(t), Cpo(t) = arterial tracer concentration for experiment i and experiment o (first experiment) in counts per second per milliliter as recorded by probe system; Ai, Ao = infused tracer activity measured by an independent detector system in counts per second per milliliter for experiments i and o; Fi, Fo = perfusate flow to the aorta in milliliters per second for experiments i and o; and K = probe efficiency/ calibration factor.
In addition, q* = KT*q*p (14) where q*, = qpe(c-)t and q* (3_Cpo AiFo 1 --~~j--.~~ (15) Fi AoKT Fiq*p C By performing several experiments on the same isolated heart at selected flow rates and plotting the results as a graph of ,8/Fi vs. Ai Fo/Fi q*p, the unknown parameters, KT and Ao, become the slope of a straight line fitted to the data [slope = Cpo/(AoKT)I. Additionally, the Y-intercept of the fitted straight line estimates -1/A (Fig. 2) .
Appendix 2: three-compartment heart model. With consideration of activity within the isolated heart chambers, the exponential infusion model can be expanded with a model that assumes some of the flow entering the heart via the aorta leaks into the left ventricle. Additionally, the model assumes that the perfusate exiting the myocardium via the coronary veins enters the right atrium and then leaves the heart via the pulmonary artery. This three-compartment model yields the following series of equations: qTOT = qM+ qL + qR (16) To avoid long delays to steady state due to KR and KL, we used the three-compartment model to estimate the myocardial tissue tracer activity from the measured total heart tracer activity as follows: qM(T) = qT(T) -FAF JqT(t)e -+axTt)dt
RT-T -T q(t)e-(KR+aXT-t dt (24)
Where qm(T), q.<T) = myocardial and total heart tracer activity for time T per unit mass of tissue; T = time after commencement of infusion of tracer; t = dummy time variable of integration; and FA, Fp = flow of aortic and pulmonary perfusate; KL, KR, KM = left ventricular, right atrial, and myocardial turnover rate of tracer; a = isotope decay constant; and I = mean transit time of tracer through myocardium. The computed myocardial tracer activity, q,,(T), can then be used to find the steady-state derived tissue activity parameter, q*, which is subsequently used in the linearized flow Eq. 6.
